文献速递临床试验与 GCP医学人工智能与信息学

优化AVATAR疗法用于痛苦幻听患者:AVATAR2多中心随机对照试验研究方案

Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trial.
PubMed 文献 · Trials · 2021-05-25

AVATAR2是一项多中心平行组随机对照试验,计划独立随机分配345名精神分裂症谱系及其他精神病性障碍且痛苦幻听超过6个月的患者,比较AVATAR-brief(6次)联合常规治疗、AVATAR-extended(12次)联合常规治疗与单纯常规治疗(1:1:1)。主要结局为第16周和第28周由盲法评估者测量的PSYRATS幻听痛苦维度评分,旨在验证两种AVATAR疗法降低幻听相关痛苦的效果并评估成本效果。

要点

  • AVATAR疗法通过数字模拟声音进行三方对话,首个充分把握度随机试验显示其12周时降低幻听频率和痛苦优于支持性咨询。
  • AVATAR2独立随机分配345人至AVATAR-brief加TAU、AVATAR-extended加TAU或单纯TAU,按1:1:1分配。
  • 主要结局为第16周和第28周盲法评估的PSYRATS幻听痛苦维度评分,采用意向性治疗原则和线性混合模型分析。

核心结论

  • AVATAR2试验旨在验证AVATAR-brief和AVATAR-extended两种形式降低幻听相关痛苦的效果,并评估其成本效果。

研究设计与样本

  • 多中心平行组随机对照试验,独立随机分配345名精神分裂症谱系及其他精神病性障碍且痛苦幻听超过6个月的患者。
  • 三组按1:1:1分配:AVATAR-brief(6次)加TAU、AVATAR-extended(12次)加TAU、单纯TAU。
  • 主要结局为第16周和第28周由盲法评估者测量的PSYRATS幻听痛苦维度评分,按意向性治疗原则用线性混合模型分析。

关键数值与推荐

  • 主要结局为第16周和第28周PSYRATS幻听痛苦维度评分。
  • AVATAR-brief为6次治疗,标准化聚焦于暴露、自信和自我 esteem;AVATAR-extended为12次,第一阶段同AVATAR-brief,第二阶段为公式化驱动的个体化治疗。
  • 首个充分把握度随机试验发现AVATAR疗法在12周时降低幻听频率和相关痛苦优于支持性咨询。

临床怎么用

  • AVATAR疗法通过数字模拟声音进行三方对话,第一阶段聚焦对抗敌意声音,第二阶段声音让步并转向个体化治疗目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: AVATAR therapy is a novel intervention targeting distressing auditory verbal hallucinations (henceforth 'voices'). A digital simulation (avatar) of the voice is created and used in a three-way dialogue between participant, avatar and therapist. To date, therapy has been delivered over 6 sessions, comprising an initial phase, focusing on standing up to a hostile avatar, and a second phase in which the avatar concedes and focus shifts to individualised treatment targets, including beliefs about voices. The first fully powered randomised trial found AVATAR therapy resulted in a rapid and substantial fall in voice frequency and associated distress that was superior to supportive counselling at 12 weeks. The main objective of this AVATAR2 trial is to test the efficacy of two forms of AVATAR therapy in reducing voice-related distress: AVATAR-brief (standardised focus on exposure, assertiveness and self-esteem) and AVATAR-extended (phase 1 mirroring AVATAR-brief augmented by a formulation-driven phase 2). Secondary objectives include the examination of additional voice, wellbeing and mood outcomes, the exploration of mediators and moderators of therapy response, and examining cost-effectiveness of both forms of therapy compared with usual treatment (TAU). METHODS: This multi-site parallel group randomised controlled trial will independently randomise 345 individuals to receive AVATAR-brief (6 sessions) plus TAU or AVATAR-extended (12 sessions) plus TAU or TAU alone (1:1:1 allocation). Participants will be people with a diagnosis of schizophrenia spectrum and other psychotic disorders who have heard distressing voices for more than 6 months. The primary outcome is the PSYRATS Auditory Hallucinations Distress dimension score at 16 and 28 weeks, conducted by blinded assessors. Statistical analysis will follow the intention-to-treat principle and data will be analysed using linear mixed models. Mediation and moderation analyses using contemporary causal inference methods will be conducted as secondary analyses. Service costs will be calculated, and cost-effectiveness assessed in terms of quality-adjusted life years accrued. DISCUSSION: This study will clarify optimal therapy delivery, test efficacy in a multi-site study and enable the testing of the AVATAR software platform, therapy training and provision in NHS settings. TRIAL REGISTRATION: ISRCTN registry ISRCTN55682735 . Registered on 22 January 2020. The trial is funded by the Wellcome Trust (WT).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Garety P, Edwards CJ, Ward T, et al. Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trial. Trials. 2021. PMID: 34034792. doi:10.1186/s13063-021-05301-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。